Skip to main content

Table 1 Basic clinical and laboratory characteristics of the study groups

From: High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus

Characteristics SLE patients (n = 51) Controls (n = 49) P Value
Gender (female/male) 44/7 41/8 0.717
Age (yr) 31.82 ± 6.40 31.8 ± 6.81 0.983
BMI (kg/m2) 24.45 ± 4.13 23.86 ± 4.28 0.489
Current smoker (%) 31.37 26.53 0.484
Systolic blood pressure (mmHg) 115 (110–120) 117 (110–120) 0.952
Diastolic blood pressure (mmHg) 70 (70–80) 78 (70–80) 0.592
Glucose (mmol/L) 4.89 ± 0.77 4.32 ± 0.57 <0.001
Total cholesterol (mmol/L) 4.57 ± 1.12 4.81 ± 0.80 0.222
LDL-cholesterol (mmol/L) 2.60 ± 0.84 2.71 ± 0.69 0.473
HDL-cholesterol (mmol/L) 1.26 ± 0.47 1.71 ± 0.45 <0.001
Non-HDL cholesterol (mmol/L) 3.22 ± 1.23 3.10 ± 0.78 0.573
Triglycerides (mmol/L) 1.25 (0.9-1.9) 0.90 (0.7-1.4) 0.005
Apolipoprotein A1 (g/l) 1.39 ± 0.35 1.66 ± 0.41 <0.001
Apolipoprotein B-100 (g/l) 0.86 ± 0.26 0.76 ± 0.22 0.047
Lipoprotein (a) (mg/l) 106 (29–294) 76 (29–169) 0.240
ApoA1/HDL (g/mmol) 1.17 ± 0.26 0.99 ± 0.17 <0.001
  1. Statistically significant differences are marked in bold